Biosimilar Legislation Could Upend Interchangeability Rather Than Prevent Product Hopping

 
• By Derrick Gingery
  
auto-injector
Proposed legislation would change the interchangeability system for biosimilars of Humira and other biologics going forward. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics